Compile Data Set for Download or QSAR
Report error Found 44 Enz. Inhib. hit(s) with all data for entry = 50037810
TargetPotassium voltage-gated channel subfamily H member 2(Human)
Portola Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM22874(CHEMBL914 | Allegra | 2-(4-{1-hydroxy-4-[4-(hydrox...)
Affinity DataIC50: 2.30E+4nMAssay Description:Inhibition of human ERG potassium channel in HEK293 cells by patch clamp assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
12/9/2012
Entry Details Article
PubMed
TargetPotassium voltage-gated channel subfamily H member 2(Human)
Portola Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM22890(CHEMBL1000 | 2-(2-{4-[(4-chlorophenyl)(phenyl)meth...)
Affinity DataIC50: 3.00E+4nMAssay Description:Inhibition of human ERG potassium channel in HEK293 cells by patch clamp assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
12/9/2012
Entry Details Article
PubMed
TargetPotassium voltage-gated channel subfamily H member 2(Human)
Portola Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50117924(CHEMBL583 | Raxar | 1-Cyclopropyl-6-fluoro-5-methy...)
Affinity DataIC50: 5.00E+4nMAssay Description:Inhibition of human ERG potassium channel in HEK293 cells by patch clamp assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
12/9/2012
Entry Details Article
PubMed
TargetPotassium voltage-gated channel subfamily H member 2(Human)
Portola Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50017376(1-(4-tert-butylphenyl)-4-(4-(hydroxydiphenylmethyl...)
Affinity DataIC50: 5.60E+4nMAssay Description:Inhibition of human ERG potassium channel in HEK293 cells by patch clamp assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
12/9/2012
Entry Details Article
PubMed
TargetPotassium voltage-gated channel subfamily H member 2(Human)
Portola Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50193846(1-({4-[4-chloro-2-(5-chloro-pyridin-2-ylcarbamoyl)...)
Affinity DataKi:  16nMAssay Description:Displacement of [3H]dofetilide from human ERG potassium channel expressed in HEK293 cellsMore data for this Ligand-Target Pair
In Depth
Date in BDB:
12/9/2012
Entry Details Article
PubMed
TargetPotassium voltage-gated channel subfamily H member 2(Human)
Portola Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50193867(1-({4-[4-chloro-2-(5-chloro-pyridin-2-ylcarbamoyl)...)
Affinity DataKi:  17nMAssay Description:Displacement of [3H]dofetilide from human ERG potassium channel expressed in HEK293 cellsMore data for this Ligand-Target Pair
In Depth
Date in BDB:
12/9/2012
Entry Details Article
PubMed
TargetPotassium voltage-gated channel subfamily H member 2(Human)
Portola Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50193871(1-({4-[4-chloro-2-(5-chloro-pyridin-2-ylcarbamoyl)...)
Affinity DataKi:  51nMAssay Description:Displacement of [3H]dofetilide from human ERG potassium channel expressed in HEK293 cellsMore data for this Ligand-Target Pair
In Depth
Date in BDB:
12/9/2012
Entry Details Article
PubMed
TargetPotassium voltage-gated channel subfamily H member 2(Human)
Portola Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50193837((R)-4-(5-chloro-1H-indole-2-sulfonyl)-1-[4-(N,N-di...)
Affinity DataKi:  71nMAssay Description:Displacement of [3H]dofetilide from human ERG potassium channel expressed in HEK293 cellsMore data for this Ligand-Target Pair
In Depth
Date in BDB:
12/9/2012
Entry Details Article
PubMed
TargetPotassium voltage-gated channel subfamily H member 2(Human)
Portola Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50193868(4-{3-(5-chloro-pyridin-2-ylcarbamoyl)-4-[4-(N,N-di...)
Affinity DataKi:  71nMAssay Description:Displacement of [3H]dofetilide from human ERG potassium channel expressed in HEK293 cellsMore data for this Ligand-Target Pair
In Depth
Date in BDB:
12/9/2012
Entry Details Article
PubMed
TargetPotassium voltage-gated channel subfamily H member 2(Human)
Portola Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50193870(N-(5-chloro-pyridin-2-yl)-2-[4-(N,N-dimethyl-carba...)
Affinity DataKi:  89nMAssay Description:Displacement of [3H]dofetilide from human ERG potassium channel expressed in HEK293 cellsMore data for this Ligand-Target Pair
In Depth
Date in BDB:
12/9/2012
Entry Details Article
PubMed
TargetPotassium voltage-gated channel subfamily H member 2(Human)
Portola Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50193861(5-chloro-N-(5-chloro-pyridin-2-yl)-2-[4-(N,N-dimet...)
Affinity DataKi:  100nMAssay Description:Displacement of [3H]dofetilide from human ERG potassium channel expressed in HEK293 cellsMore data for this Ligand-Target Pair
In Depth
Date in BDB:
12/9/2012
Entry Details Article
PubMed
TargetPotassium voltage-gated channel subfamily H member 2(Human)
Portola Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50193858(N-{4-chloro-2-[(5-chloropyridin-2-yl)carbamoyl]phe...)
Affinity DataKi:  140nMAssay Description:Displacement of [3H]dofetilide from human ERG potassium channel expressed in HEK293 cellsMore data for this Ligand-Target Pair
In Depth
Date in BDB:
12/9/2012
Entry Details Article
PubMed
TargetPotassium voltage-gated channel subfamily H member 2(Human)
Portola Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50193849(N-{2-[(5-chloropyridin-2-yl)carbamoyl]-4-methoxyph...)
Affinity DataKi:  200nMAssay Description:Displacement of [3H]dofetilide from human ERG potassium channel expressed in HEK293 cellsMore data for this Ligand-Target Pair
In Depth
Date in BDB:
12/9/2012
Entry Details Article
PubMed
TargetPotassium voltage-gated channel subfamily H member 2(Human)
Portola Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50193852(N-(5-Chloro-pyridin-2-yl)-2-[4-(N,N-dimethyl-carba...)
Affinity DataKi:  370nMAssay Description:Displacement of [3H]dofetilide from human ERG potassium channel expressed in HEK293 cellsMore data for this Ligand-Target Pair
In Depth
Date in BDB:
12/9/2012
Entry Details Article
PubMed
TargetPotassium voltage-gated channel subfamily H member 2(Human)
Portola Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50113584(3-(3-carbamimidoyl-phenyl)-2-fluoro-but-2-enoic ac...)
Affinity DataKi:  530nMAssay Description:Displacement of [3H]dofetilide from human ERG potassium channel expressed in HEK293 cellsMore data for this Ligand-Target Pair
In Depth
Date in BDB:
12/9/2012
Entry Details Article
PubMed
TargetPotassium voltage-gated channel subfamily H member 2(Human)
Portola Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50193838(4-{3-(5-chloro-pyridin-2-ylcarbamoyl)-4-[4-(N,N-di...)
Affinity DataKi:  570nMAssay Description:Displacement of [3H]dofetilide from human ERG potassium channel expressed in HEK293 cellsMore data for this Ligand-Target Pair
In Depth
Date in BDB:
12/9/2012
Entry Details Article
PubMed
TargetPotassium voltage-gated channel subfamily H member 2(Human)
Portola Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50144143(2-{4-(6-Chloro-benzo[b]thiophene-2-sulfonyl)-1-[4-...)
Affinity DataKi:  600nMAssay Description:Displacement of [3H]dofetilide from human ERG potassium channel expressed in HEK293 cellsMore data for this Ligand-Target Pair
In Depth
Date in BDB:
12/9/2012
Entry Details Article
PubMed
TargetPotassium voltage-gated channel subfamily H member 2(Human)
Portola Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50193859(1-[2-[2-(5-chloro-pyridin-2-ylcarbamoyl)-4-methoxy...)
Affinity DataKi:  600nMAssay Description:Displacement of [3H]dofetilide from human ERG potassium channel expressed in HEK293 cellsMore data for this Ligand-Target Pair
In Depth
Date in BDB:
12/9/2012
Entry Details Article
PubMed
TargetPotassium voltage-gated channel subfamily H member 2(Human)
Portola Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50193862(3-{3-(5-chloro-pyridin-2-ylcarbamoyl)-4-[4-(N,N-di...)
Affinity DataKi:  790nMAssay Description:Displacement of [3H]dofetilide from human ERG potassium channel expressed in HEK293 cellsMore data for this Ligand-Target Pair
In Depth
Date in BDB:
12/9/2012
Entry Details Article
PubMed
TargetPotassium voltage-gated channel subfamily H member 2(Human)
Portola Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50193865(2-(3-cyano-naphthalen-2-yl)-5-methyl-2H-pyrazole-3...)
Affinity DataKi:  880nMAssay Description:Displacement of [3H]dofetilide from human ERG potassium channel expressed in HEK293 cellsMore data for this Ligand-Target Pair
In Depth
Date in BDB:
12/9/2012
Entry Details Article
PubMed
TargetPotassium voltage-gated channel subfamily H member 2(Human)
Portola Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50193854({3-(5-chloro-pyridin-2-ylcarbamoyl)-4-[4-(N,N-dime...)
Affinity DataKi:  970nMAssay Description:Displacement of [3H]dofetilide from human ERG potassium channel expressed in HEK293 cellsMore data for this Ligand-Target Pair
In Depth
Date in BDB:
12/9/2012
Entry Details Article
PubMed
TargetPotassium voltage-gated channel subfamily H member 2(Human)
Portola Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50193839(2-(3-fluoro-naphthalen-2-yl)-5-methyl-2H-pyrazole-...)
Affinity DataKi:  1.00E+3nMAssay Description:Displacement of [3H]dofetilide from human ERG potassium channel expressed in HEK293 cellsMore data for this Ligand-Target Pair
In Depth
Date in BDB:
12/9/2012
Entry Details Article
PubMed
TargetPotassium voltage-gated channel subfamily H member 2(Human)
Portola Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50193855(4-({4-[4-chloro-2-(5-chloro-pyridin-2-ylcarbamoyl)...)
Affinity DataKi:  1.40E+3nMAssay Description:Displacement of [3H]dofetilide from human ERG potassium channel expressed in HEK293 cellsMore data for this Ligand-Target Pair
In Depth
Date in BDB:
12/9/2012
Entry Details Article
PubMed
TargetPotassium voltage-gated channel subfamily H member 2(Human)
Portola Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50193869(({4-[4-chloro-2-(5-chloro-pyridin-2-ylcarbamoyl)-p...)
Affinity DataKi:  1.40E+3nMAssay Description:Displacement of [3H]dofetilide from human ERG potassium channel expressed in HEK293 cellsMore data for this Ligand-Target Pair
In Depth
Date in BDB:
12/9/2012
Entry Details Article
PubMed
TargetPotassium voltage-gated channel subfamily H member 2(Human)
Portola Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50193845(1-[2-[4-chloro-2-(5-chloro-pyridin-2-ylcarbamoyl)-...)
Affinity DataKi:  1.60E+3nMAssay Description:Displacement of [3H]dofetilide from human ERG potassium channel expressed in HEK293 cellsMore data for this Ligand-Target Pair
In Depth
Date in BDB:
12/9/2012
Entry Details Article
PubMed
TargetPotassium voltage-gated channel subfamily H member 2(Human)
Portola Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50193843(1-[2-[4-chloro-2-(5-chloro-pyridin-2-ylcarbamoyl)-...)
Affinity DataKi: >2.00E+3nMAssay Description:Displacement of [3H]dofetilide from human ERG potassium channel expressed in HEK293 cellsMore data for this Ligand-Target Pair
In Depth
Date in BDB:
12/9/2012
Entry Details Article
PubMed
TargetPotassium voltage-gated channel subfamily H member 2(Human)
Portola Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50123420(7-[({4-[1-(1-Imino-ethyl)-piperidin-4-yloxy]-pheny...)
Affinity DataKi:  3.90E+3nMAssay Description:Displacement of [3H]dofetilide from human ERG potassium channel expressed in HEK293 cellsMore data for this Ligand-Target Pair
In Depth
Date in BDB:
12/9/2012
Entry Details Article
PubMed
TargetPotassium voltage-gated channel subfamily H member 2(Human)
Portola Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50193860(4-{3-(5-chloro-pyridin-2-ylcarbamoyl)-4-[4-(N,N-di...)
Affinity DataKi:  4.60E+3nMAssay Description:Displacement of [3H]dofetilide from human ERG potassium channel expressed in HEK293 cellsMore data for this Ligand-Target Pair
In Depth
Date in BDB:
12/9/2012
Entry Details Article
PubMed
TargetPotassium voltage-gated channel subfamily H member 2(Human)
Portola Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50193856(4-{[2-[4-chloro-2-(5-chloro-pyridin-2-ylcarbamoyl)...)
Affinity DataKi: >6.60E+3nMAssay Description:Displacement of [3H]dofetilide from human ERG potassium channel expressed in HEK293 cellsMore data for this Ligand-Target Pair
In Depth
Date in BDB:
12/9/2012
Entry Details Article
PubMed
TargetPotassium voltage-gated channel subfamily H member 2(Human)
Portola Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50193850({3-(5-chloro-pyridin-2-ylcarbamoyl)-4-[4-(N,N-dime...)
Affinity DataKi: >1.00E+4nMAssay Description:Displacement of [3H]dofetilide from human ERG potassium channel expressed in HEK293 cellsMore data for this Ligand-Target Pair
In Depth
Date in BDB:
12/9/2012
Entry Details Article
PubMed
TargetPotassium voltage-gated channel subfamily H member 2(Human)
Portola Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50193857(1-({4-[4-chloro-2-(5-chloro-pyridin-2-ylcarbamoyl)...)
Affinity DataKi: >1.00E+4nMAssay Description:Displacement of [3H]dofetilide from human ERG potassium channel expressed in HEK293 cellsMore data for this Ligand-Target Pair
In Depth
Date in BDB:
12/9/2012
Entry Details Article
PubMed
TargetPotassium voltage-gated channel subfamily H member 2(Human)
Portola Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50193872(1-({4-[4-chloro-2-(5-chloro-pyridin-2-ylcarbamoyl)...)
Affinity DataKi: >1.00E+4nMAssay Description:Displacement of [3H]dofetilide from human ERG potassium channel expressed in HEK293 cellsMore data for this Ligand-Target Pair
In Depth
Date in BDB:
12/9/2012
Entry Details Article
PubMed
TargetPotassium voltage-gated channel subfamily H member 2(Human)
Portola Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50193840(1-(2-(4-chloro-2-(5-chloropyridin-2-ylcarbamoyl)ph...)
Affinity DataKi: >1.00E+4nMAssay Description:Displacement of [3H]dofetilide from human ERG potassium channel expressed in HEK293 cellsMore data for this Ligand-Target Pair
In Depth
Date in BDB:
12/9/2012
Entry Details Article
PubMed
TargetPotassium voltage-gated channel subfamily H member 2(Human)
Portola Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50144135(1-(2-{4-(6-chloro-benzo[b]thiophene-2-sulfonyl)-1-...)
Affinity DataKi: >1.00E+4nMAssay Description:Displacement of [3H]dofetilide from human ERG potassium channel expressed in HEK293 cellsMore data for this Ligand-Target Pair
In Depth
Date in BDB:
12/9/2012
Entry Details Article
PubMed
TargetPotassium voltage-gated channel subfamily H member 2(Human)
Portola Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50193851(4-{3-(5-chloro-pyridin-2-ylcarbamoyl)-4-[4-(N,N-di...)
Affinity DataKi: >1.00E+4nMAssay Description:Displacement of [3H]dofetilide from human ERG potassium channel expressed in HEK293 cellsMore data for this Ligand-Target Pair
In Depth
Date in BDB:
12/9/2012
Entry Details Article
PubMed
TargetPotassium voltage-gated channel subfamily H member 2(Human)
Portola Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50193864(3-{5-[4-(imino-pyrrolidin-1-yl-methyl)-phenylcarba...)
Affinity DataKi: >1.00E+4nMAssay Description:Displacement of [3H]dofetilide from human ERG potassium channel expressed in HEK293 cellsMore data for this Ligand-Target Pair
In Depth
Date in BDB:
12/9/2012
Entry Details Article
PubMed
TargetPotassium voltage-gated channel subfamily H member 2(Human)
Portola Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50193866(1-(3'-fluoro-4'-{[2-(3-fluoro-naphthalen-2-yl)-5-m...)
Affinity DataKi: >1.00E+4nMAssay Description:Displacement of [3H]dofetilide from human ERG potassium channel expressed in HEK293 cellsMore data for this Ligand-Target Pair
In Depth
Date in BDB:
12/9/2012
Entry Details Article
PubMed
TargetPotassium voltage-gated channel subfamily H member 2(Human)
Portola Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50193848(1-({4-[4-chloro-2-(5-chloro-pyridin-2-ylcarbamoyl)...)
Affinity DataKi: >1.00E+4nMAssay Description:Displacement of [3H]dofetilide from human ERG potassium channel expressed in HEK293 cellsMore data for this Ligand-Target Pair
In Depth
Date in BDB:
12/9/2012
Entry Details Article
PubMed
TargetPotassium voltage-gated channel subfamily H member 2(Human)
Portola Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50193841(1-(2-{4-(6-chloro-benzo[b]thiophene-2-sulfonyl)-1-...)
Affinity DataKi: >1.00E+4nMAssay Description:Displacement of [3H]dofetilide from human ERG potassium channel expressed in HEK293 cellsMore data for this Ligand-Target Pair
In Depth
Date in BDB:
12/9/2012
Entry Details Article
PubMed
TargetPotassium voltage-gated channel subfamily H member 2(Human)
Portola Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50193842(1-(2-(2-(5-chloropyridin-2-ylcarbamoyl)-4-methoxyp...)
Affinity DataKi: >1.00E+4nMAssay Description:Displacement of [3H]dofetilide from human ERG potassium channel expressed in HEK293 cellsMore data for this Ligand-Target Pair
In Depth
Date in BDB:
12/9/2012
Entry Details Article
PubMed
TargetPotassium voltage-gated channel subfamily H member 2(Human)
Portola Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50193863([[-3-(3-arbamimidoyl-phenyl)-2-fluoro-but-2-enoyl]...)
Affinity DataKi: >1.00E+4nMAssay Description:Displacement of [3H]dofetilide from human ERG potassium channel expressed in HEK293 cellsMore data for this Ligand-Target Pair
In Depth
Date in BDB:
12/9/2012
Entry Details Article
PubMed
TargetPotassium voltage-gated channel subfamily H member 2(Human)
Portola Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50084617(YM-60828 | ((7-carbamimidoyl-naphthalen-2-ylmethyl...)
Affinity DataKi: >1.00E+4nMAssay Description:Displacement of [3H]dofetilide from human ERG potassium channel expressed in HEK293 cellsMore data for this Ligand-Target Pair
In Depth
Date in BDB:
12/9/2012
Entry Details Article
PubMed
TargetPotassium voltage-gated channel subfamily H member 2(Human)
Portola Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50193853((R)-4-(5-chloro-1H-indole-2-sulfonyl)-1-[4-(N,N-di...)
Affinity DataKi: >1.00E+4nMAssay Description:Displacement of [3H]dofetilide from human ERG potassium channel expressed in HEK293 cellsMore data for this Ligand-Target Pair
In Depth
Date in BDB:
12/9/2012
Entry Details Article
PubMed
TargetPotassium voltage-gated channel subfamily H member 2(Human)
Portola Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50193844(3-{3-(5-chloro-pyridin-2-ylcarbamoyl)-4-[4-(N,N-di...)
Affinity DataKi: >1.00E+4nMAssay Description:Displacement of [3H]dofetilide from human ERG potassium channel expressed in HEK293 cellsMore data for this Ligand-Target Pair
In Depth
Date in BDB:
12/9/2012
Entry Details Article
PubMed